Creative Commons source reading · Neurodegeneration biomarkers and longitudinal studies
In pursuit of degenerative brain disease diagnosis: Dementia biomarkers detected by DNA aptamer-attached portable graphene biosensor.
Tyler Andrew Bodily; Anirudh Ramanathan; Shanhong Wei; Abhijith Karkisaval; Nemil Bhatt; Cynthia Jerez; Md Anzarul Haque; Armando Ramil; Prachi Heda; Yi Wang; Sanjeev Kumar; Mikayla Leite; Tie Li; Jianlong Zhao; Ratnesh Lal
Originally published in Proceedings of the National Academy of Sciences of the United States of America · 2023-11-13
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Dementia is a brain disease which results in irreversible and progressive loss of cognition and motor activity. Despite global efforts, there is no simple and reliable diagnosis or treatment option. Current diagnosis involves indirect testing of commonly inaccessible biofluids and low-resolution brain imaging. We have developed a portable, wireless readout-based Graphene field-effect transistor (GFET) biosensor platform that can detect viruses, proteins, and small molecules with single-molecule sensitivity and specificity. We report the detection of three important amyloids, namely, Amyloid beta (Aβ), Tau (τ), and α-Synuclein (αS) using DNA aptamer nanoprobes. These amyloids were isolated, purified, and characterized from the autopsied brain tissues of Alzheimer's Disease (AD) and Parkinson's Disease (PD) patients. The limit of detection (LoD) of the sensor is 10 fM, 1-10 pM, 10-100 fM for Aβ, τ, and αS, respectively. Synthetic as well as autopsied brain-derived amyloids showed a statistically significant sensor response with respect to derived thresholds, confirming the ability to define diseased vs. nondiseased states.
Discussion
The world is continuing to face an increasingly aging population, which is exacerbated by declining birth rates and increased life expectancy. This brings to the forefront of modern medicine the need to better understand, prevent, and treat elderly patients who are at risk of developing AD, PD, and other neurodegenerative diseases. In addition to age-related risk factors, traumatic brain injury (TBI) is being studied as a potential risk factor for the development of neurodegenerative disease such as AD or encephalopathy (28).
Editorial reading guide
- Was the evidence cross-sectional, longitudinal or experimental?
- How did the authors account for age, disease stage and differences among participants?
